You are here

Article info

Article menu
Co-morbidities
Original research
Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE

Authors

  • Sudha Raghunath Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, AustraliaDepartment of Rheumatology, Monash Health, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Yifat Glikmann-Johnston Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Eric Morand Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, AustraliaDepartment of Rheumatology, Monash Health, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Julie C Stout Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Alberta Hoi Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, AustraliaDepartment of Rheumatology, Monash Health, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sudha Raghunath; sudha.raghunath{at}monash.edu
View Full Text

Citation

Raghunath S, Glikmann-Johnston Y, Morand E, et al
Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
Lupus Science & Medicine 2021;8:e000580. doi: 10.1136/lupus-2021-000580

Publication history

  • Received September 13, 2021
  • Accepted November 19, 2021
  • First published December 15, 2021.
Online issue publication 
July 06, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.